MCW Biophysics News

Please wait while we gather your results.

Giving an Old Drug New Potential

The results of Dr. Kalyanaraman lab's work to modify a well-established diabetes drug (metformin) for use in pancreatic cancer is published.

Dr. Kalyanaraman teaches cancer course at Anna University in Chennai, India

Dec. 20 - Balaraman Kalyanaraman, PhD, Harry R. & Angeline E. Quadracci Professor in Parkinson’s Research, chairman and professor of biophysics and founder of the MCW Free Radical Research Center, was recently invited to teach a course on “Targeting Cancer Metabolism” to students at Anna University in Chennai, Tamil Nadu, India.

MCW team participates in International Workshop on EPR in Biology and Medicine

Oct. 17 - MCW researchers participated in the 10th International Workshop on EPR in Biology and Medicine, held Oct. 2-6. Balaraman Kalyanaraman, PhD, chair and professor of biophysics and Harry R. and Angeline E. Quadracci Professor in Parkinson’s Research, co-chaired the event.

Biophysics researchers discuss oxidants and redox signaling in cells

Sept. 19 - Balaraman Kalyanaraman, PhD, chair and professor of biophysics and the Harry R. & Angeline E. Quadracci Professor in Parkinson’s Research, and his research team had their review article, Recent developments in detection of superoxide radical anion and hydrogen peroxide: Opportunities, challenges, and implications in redox signaling, published in Archives of Biochemistry and Biophysics’s special issue on redox signaling.

MCW researchers report potential mitochondrial drug therapy for pancreatic cancer

May 26 - Balaraman Kalyanaraman, PhD, chairman and professor of biophysics and Harry R. & Angeline E. Quadracci Professor in Parkinson’s Research; Michael B. Dwinell, PhD, professor of microbiology and molecular genetics; and their international research team published an article in Cancer Research that describes a new redox-sensitive, mitochondrial-energy-sensor-mediated pathway of regression of pancreatic cancer cell growth.

Medical College of Wisconsin receives $5.5 million grant to study Alzheimer’s disease

May 2 - The Medical College of Wisconsin (MCW), in collaboration with the University of Wisconsin-Madison (UW-Madison), has received a four-year, $5.5 million grant from the National Institutes of Health’s (NIH) National Institute on Aging to study Alzheimer’s disease. The study, called the Alzheimer’s Disease Connectome Project, will use the Human Connectome Project approach, which is aimed at constructing a map of the neural connections within and across individuals, to perform brain imaging on 300 elderly individuals.

Media Contacts

Holly Botsford
External Communications Lead
Medical College of Wisconsin
(414) 955-8761 (Office)
(414) 688-7960 (Cell)

Alex Krouse
External Communications Specialist
Medical College of Wisconsin
(414) 955-5825 (Office)
(414) 491-7156 (Cell)

media@mcw.edu

Top